Interestingly, however, this study shows that for patients with joint complaints suspected of having RA and with a weakly positive CCP 2 (≥7 and ≤16 U/ml), CCP3 testing could be of additive value for diagnosing RA. This evidence concerns the gene AGBL3 and rheumatoid arthritis.